L-FABP関連文献
このコーナーでは、L-FABP関連の論文を、慢性腎臓病(CKD)、急性腎障害(AKI)、Toxicology、Pharmacologyに分類し、紹介いたします。
文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号(文献リストの赤色の数字)を入力の上、ご連絡ください。
文献カテゴリー
慢性腎臓病(CKD) 【新着】
-
232
Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.
Biomedicines. 2024
doi: 10.3390/biomedicines12081789. PubMed -
231
Estimated proximal tubule fluid phosphate concentration and renal tubular damage biomarkers in early stages of chronic kidney disease.
J Ren Nutr. 2024
doi: 10.1053/j.jrn.2024.06.009. PubMed -
226
Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder-A Pilot Study.
J Clin Med. 2024
doi: 10.3390/jcm13030736. PubMed -
224
Comparison of Urinary Liver Fatty Acid Binding Protein Level and Pathologic Biopsy Findings 1 Year After Kidney Transplantation.
Transplant Proc. 2024
doi: 10.1016/j.transproceed.2023.12.016. PubMed -
218
Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease.
J Pers Med. 2023
doi: 10.3390/jpm13101481. PubMed -
214
Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes.
Biomedicines. 2023
doi: 10.3390/biomedicines11113020. PubMed
急性腎障害(AKI) 【新着】
-
230
Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study.
Ann Intensive Care.2024
doi: 10.1186/s13613-024-01328-9. PubMed -
229
Urinary liver-type fatty acid-binding protein level as a prognostic indicator of acute kidney injury secondary to severe falciparum malaria.
CEN Case Rep.2024
doi: 10.1007/s13730-024-00886-y. PubMed -
228
Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis.
Int J Mol Sci.2024
doi: 10.3390/ijms25094912. PubMed -
227
Urinary liver-type fatty acid-binding protein levels may be associated with the occurrence of acute kidney injury induced by trauma.
Front Med (Lausanne). 2024
doi: 10.3389/fmed.2024.1346183. PubMed -
225
Urine oxygenation predicts COVID 19 risk.
Clin Exp Nephrol. 2024
doi: 10.1007/s10157-023-02456-5. PubMed
薬剤性腎障害(Toxicology) 【新着】
-
201
Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report. Open Vet J.2022
doi: 10.5455/OVJ.2022.v12.i6.12 PubMed -
188
Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury. BMC Nephrol.2022
doi: 10.1186/s12882-022-02760-4. PubMed -
184
Clinical Utility of a Biomarker to Detect Contrast-Induced AcuteKidney Injury during Percutaneous Cardiovascular Procedures.
Cardiorenal Med.2022
doi: 10.1159/000520820. PubMed -
167
Changing trends in lipid profile and biomarkers of renalfunction and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofoviralafenamide: a prospective observational study.
AIDS Res Ther.2021
doi:10.1186/s12981-021-00354-y. PubMed -
153
Early changes in tubular dysfunction markers and phosphorusmetabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleosideanalog therapy for chronic hepatitis B patients.
Hepatol Res.2020
doi:10.1111/hepr.13451. PubMed
薬理学(Pharmacology) 【新着】
-
217
Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Nephrology (Carlton). 2023
doi: 10.1111/nep.14254. PubMed -
206
Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments.
J Am Heart Assoc.2023
doi: 10.1161/JAHA.122.028146. PubMed -
205
Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients.
Int Urol Nephrol.2023
doi: 10.1007/s11255-023-03532-1. PubMed -
182
Tubular Injury Causing Protracted GlycosuriaFollowing Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in theDevelopment of Protracted Hypoglycemia and Ketoacidosis.
Tohoku J ExpMed.2021
doi: 10.1620/tjem.255.291. PubMed
運動(Exercise)/ 熱中症(Heatstroke) 【新着】
- 195Early biomarkers for kidney injury in heat-related illness patients: a prospective observational study at Japanese Self-Defense Force Fuji Hospital. Nephrol Dial Transplant.
2022
doi: 10.1093/ndt/gfac166. PubMed -
197
The moderate-intensity continuous exercise maintains renal blood flow and does not impair the renal function .
Physiol Rep. 2022
doi: 10.14814/phy2.15420. PubMed -
194
Xanthine Oxidoreductase Activity in MarathonRunners: Potential Implications for Marathon-Induced Acute Kidney Injury.
JAppl Physiol. 2022
doi: 10.1152/japplphysiol.00669.2021. PubMed -
181
Wearing a face mask during controlled-intensity exercise is nota risk factor for exertional heatstroke: A pilot study.
Acute MedSurg.2021
doi: 10.1002/ams2.712. PubMed -
178
Exercise Ameliorates Diabetic Kidney Disease in Type 2 DiabeticFatty Rats.
Antioxidants (Basel).2021
doi: 10.3390/antiox10111754. PubMed
新型コロナウイルス感染症(COVID-19) 【新着】
-
225
Urine oxygenation predicts COVID 19 risk.
Clin Exp Nephrol. 2024
doi: 10.1007/s10157-023-02456-5. PubMed -
217
Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Nephrology (Carlton). 2023
doi: 10.1111/nep.14254. PubMed - J49 当院での新型コロナウイルス感染症(COVID-19)入院患者から検討した重症化予測因子 内科2023
-
209
Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
Nephrology (Carlton).2023
DOI: 10.1111/nep.14162 PubMed -
208
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases.
Care Explor. 2023
doi: 10.1097/CCE.0000000000000873. PubMed
日本語総説 【新着】
- J54 尿細管マーカーの見方 臨床検査68(4) 2024
- J53 犬における尿中L-FABPの臨床的意義 未病の科学3 2024
- J52 未病と尿中L-FABP 未病の科学3 2024
- J51 バイオマーカーが捉える心血管疾患患者における急性腎障害 臨床化学52(1) 2023
- J50 腎臓病の克服を目指して 金沢大学十全医学会雑誌132(1) 2023
ガイドラインなど
文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号(下記リストの最初の数字)を入力の上、ご連絡ください。